Unigestion Holding SA Raises Holdings in Colgate-Palmolive (NYSE:CL)

Unigestion Holding SA boosted its holdings in shares of Colgate-Palmolive (NYSE:CL - Free Report) by 301.4% during the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 325,056 shares of the company's stock after buying an additional 244,071 shares during the quarter. Colgate-Palmolive makes up approximately 1.6% of Unigestion Holding SA's investment portfolio, making the stock its 24th largest position. Unigestion Holding SA's holdings in Colgate-Palmolive were worth $33,738,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also recently bought and sold shares of the business. State Street Corp raised its stake in Colgate-Palmolive by 3.8% in the 3rd quarter. State Street Corp now owns 48,436,276 shares of the company's stock valued at $5,028,170,000 after acquiring an additional 1,784,411 shares during the period. Geode Capital Management LLC raised its position in shares of Colgate-Palmolive by 2.8% in the third quarter. Geode Capital Management LLC now owns 20,193,331 shares of the company's stock valued at $2,095,325,000 after purchasing an additional 552,949 shares during the period. Massachusetts Financial Services Co. MA lifted its stake in shares of Colgate-Palmolive by 6.2% during the 3rd quarter. Massachusetts Financial Services Co. MA now owns 9,526,990 shares of the company's stock worth $988,997,000 after buying an additional 557,492 shares during the last quarter. Legal & General Group Plc boosted its holdings in shares of Colgate-Palmolive by 0.8% during the 2nd quarter. Legal & General Group Plc now owns 7,785,101 shares of the company's stock worth $755,465,000 after buying an additional 61,413 shares during the period. Finally, Barclays PLC grew its stake in Colgate-Palmolive by 38.7% in the 3rd quarter. Barclays PLC now owns 7,644,189 shares of the company's stock valued at $793,542,000 after buying an additional 2,132,747 shares during the last quarter. Institutional investors own 80.41% of the company's stock.

Colgate-Palmolive Stock Down 1.2 %

Colgate-Palmolive stock traded down $1.13 during mid-day trading on Wednesday, reaching $92.76. The stock had a trading volume of 3,629,384 shares, compared to its average volume of 4,381,511. The company has a debt-to-equity ratio of 9.46, a quick ratio of 0.68 and a current ratio of 1.04. Colgate-Palmolive has a fifty-two week low of $75.50 and a fifty-two week high of $109.30. The stock's 50-day simple moving average is $96.16 and its 200-day simple moving average is $98.66. The firm has a market capitalization of $75.79 billion, a PE ratio of 27.02, a price-to-earnings-growth ratio of 3.36 and a beta of 0.43.

Colgate-Palmolive Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, February 14th. Stockholders of record on Tuesday, January 21st will be paid a $0.50 dividend. This represents a $2.00 annualized dividend and a dividend yield of 2.16%. Colgate-Palmolive's dividend payout ratio (DPR) is presently 57.31%.

Insider Activity at Colgate-Palmolive

In other Colgate-Palmolive news, CFO Stanley J. Sutula III sold 45,410 shares of the stock in a transaction dated Tuesday, November 5th. The shares were sold at an average price of $94.11, for a total value of $4,273,535.10. Following the completion of the sale, the chief financial officer now owns 36,726 shares in the company, valued at approximately $3,456,283.86. This trade represents a 55.29 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. 0.37% of the stock is owned by insiders.

Wall Street Analysts Forecast Growth

A number of brokerages have recently issued reports on CL. Deutsche Bank Aktiengesellschaft cut Colgate-Palmolive from a "buy" rating to a "hold" rating and boosted their price objective for the stock from $107.00 to $109.00 in a report on Monday, September 9th. StockNews.com raised Colgate-Palmolive from a "hold" rating to a "buy" rating in a report on Monday, November 25th. JPMorgan Chase & Co. upped their price target on shares of Colgate-Palmolive from $113.00 to $114.00 and gave the company an "overweight" rating in a research note on Friday, October 11th. Piper Sandler assumed coverage on shares of Colgate-Palmolive in a report on Tuesday, September 24th. They issued an "overweight" rating and a $121.00 price objective for the company. Finally, Stifel Nicolaus cut shares of Colgate-Palmolive from a "buy" rating to a "hold" rating and lowered their target price for the stock from $105.00 to $101.00 in a report on Monday, October 28th. One equities research analyst has rated the stock with a sell rating, nine have issued a hold rating and thirteen have given a buy rating to the company's stock. Based on data from MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and an average target price of $105.11.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.